Captek Softgel International Acquires J+D Labs
Captek Softgel International Acquires J+D Labs
Cerritos and Vista, CA – August 4, 2017 – California-based Captek Softgel International, Inc. (CSI), a leading contract manufacturer of custom dietary supplements is pleased to announce its acquisition of J+D Labs Pharma Manufacturing, Inc. Captek Softgel International is a portfolio company of Swander Pace Capital, and the acquisition of J+D Labs is a continuation of SPC’s focus on investing in and growing industry-leading vitamin, mineral, and supplement companies.
For decades J+D Labs has been well recognized in the nutraceutical industry as a first-class manufacturer of health and wellness supplements producing more than 1,000 unique formulations. More recently J+D Labs has brought NutraStock® to the market, more than 250 bulk stock dietary supplements manufactured in the USA.
Captek CEO David Wood said this union will result in a greater diversity of offerings and services within the supplement channel. “We have long regarded J+D Labs’ reputation and the significance of what they bring to the table as a leader in the industry,” he said. J+D Labs’ extensive experience manufacturing a wide-range of softgels, specialized tablets, capsules, and powder formulations was a perfect complement to Captek’s offerings. Wood stated, “Going forward, we are committed to our collective success through focusing on our customers, sharing best practices, and continuing our best-in-class quality and compliance standards.”
“This acquisition is positive for everyone: for our employees, our suppliers, our customers, and the end-users,” said J+D Labs owner, Jay Majmudar. CSI is well established in more than 20 countries. “We are happy to play a key role in helping to expand distribution even further. We will continue to make quality, price, and timely delivery a top priority,” emphasized Majmudar.
The newly joined companies will continue to produce high quality products in both Cerritos and Vista, CA. This will give customers the business continuity planning they have long sought by having the ability to have their products manufactured at either site. As a result, more than 300,000 square feet of manufacturing, warehousing, and analytical testing labs will immediately bring to market greater capacity, expertise, comprehensive turnkey packaging, the benefits of enteric coating, and more.
In the coming months the combined company will work with its customer-facing teams to communicate its newly expanded product and service offerings to both existing and prospective customers.
About Captek Softgel International, Inc.
Captek Softgel International, Inc. (CSI) is a privately-owned, FDA registered and audited, GMP-certified, full-service contract manufacturer of custom dietary supplement formulations.
CSI features high efficiency encapsulation lines operating 24/5, capable of producing more than three billion softgels annually. The facility encompasses approximately 163,000 square feet of production, analytical laboratory, pilot laboratory, and warehousing space. Captek fully complies with FDA cGMP’s and has been independently certified by NSF International. For more information, visit www.capteksoftgel.com.
About Swander Pace Capital
Swander Pace Capital (SPC) is a private equity firm that invests in companies that are integral to consumers’ lives. SPC’s consumer industry expertise informs the firm’s strategic approach and adds value through access to its proven SPC Playbook, senior team and extensive network. The firm partners with management teams to help build companies to their full potential. SPC invests in businesses across three domains of consumer lifestyles: Food & Beverage, Body & Wellness and Home & Family. With offices in San Francisco, New Jersey and Toronto, SPC has invested in more than 45 companies and raised cumulative equity commitments of approximately $1.8 billion since 1996. SPC’s current investments in the vitamin, mineral, and supplement industry include Captek Softgel International, Inc., Swanson Health Products, and Reliance Holdings, in additional to its prior ownership of ReNew Life Formulas, Inc. and Santa Cruz Nutritionals. For more information, visit www.spcap.com.
About J+D Labs Pharma Manufacturing, Inc.
J+D Labs is a privately-owned, premier, custom manufacturer of nutraceuticals based in Vista, California. With more than 25 years’ experience in the industry, they have grown their business to include more than 300 team members including pharmacists, microbiologists, administrative staff, skilled technicians, engineers and chemists—all working together in a state-of-the-art, 135,000-square-foot facility to produce the highest quality dietary supplements. For more information visit www.jdlabs.com.
